How can a doctor in a small practice with only one or two GPs learn from the mistakes of doctors across the country?
The chances of surviving melanoma are getting better every year. But some cancers still become ‘resistant’ to treatment, and others don’t respond at all.
You’re in hospital: should you stay? Should you leave? What’s your risk of dying?
Recent advances pinpointing genes involved in the inherited form of Motor Neurone Disease (MND) are now being used to hunt for the culprits of ‘sporadic’ cases.
Almost everyone has had their blood pressure measured with an inflatable cuff around the arm. But as useful as this is, it can differ from the reading at the heart itself.
Dr Edwin Lim proposed the first biomarker to discriminate MS clinical subtypes using tryptophan metabolomics. His work aims to deliver a reliable prognostic biomarker to track neurological and mental wellbeing.
Current methods used for colorectal cancer screening are inadequate on both sensitivity and specificity grounds while morbidity and mortality of this malignancy remain high. Minimally invasive blood-based tests may overcome this issue.
Chronic kidney disease effects approximately 7% of the world population with the number of cases reaching end-stage renal disease growing at 3% annually. Higher degree researchers from Macquarie investigate the role hypertension plays in cases of chronic kidney disease.
This project aims to measure Cerebrospinal fluid pressure non-invasively using the vessels of ocular circulation.
MND Australia has awarded a $1.05 million Ice Bucket Challenge Grant to the Sporadic ALS Australian Systems Consortium. Associate Professor Ian Blair of the Faculty of Medicine and Health Sciences will lead the project with Professor Naomi Gray of the University of Queensland’s Brain Institute.